lobbying_activities: 1071565

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1071565	68e8c93f-5eed-443a-8a64-2c1994d86d3e	Q1	HOLLAND & KNIGHT LLP	18466	SHIRE PHARMACEUTICALS, INC	2011	first_quarter	MED	Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products. Participate in FDA stakeholder meetings re Prescription Drug User Fee program.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2011-04-06T12:42:13.967000-04:00